Usefulness of Serum Cathepsin L as an Independent Biomarker in Patients With Coronary Heart Disease

Higher levels of cysteinyl cathepsin L were detected in human atherosclerotic lesions than in healthy aortas. However, a link between human coronary heart disease (CHD) and systemic cathepsin L levels remains unknown. A total of 137 volunteers with diagnosed acute and previous myocardial infarction...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of cardiology Vol. 103; no. 4; pp. 476 - 481
Main Authors Liu, Yingxian, Li, Xiangping, Peng, Daoquan, Tan, Zheng, Liu, Hongmin, Qing, Yingnan, Xue, Yanqiong, Shi, Guo-Ping
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 15.02.2009
Elsevier
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Higher levels of cysteinyl cathepsin L were detected in human atherosclerotic lesions than in healthy aortas. However, a link between human coronary heart disease (CHD) and systemic cathepsin L levels remains unknown. A total of 137 volunteers with diagnosed acute and previous myocardial infarction (MI) and stable and unstable angina pectoris in addition to 48 controls were asked to undergo coronary angiography. Serum cathepsin L, high-sensitivity C-reactive protein, fasting glucose, and lipid protein profiles were measured. Serum cathepsin L levels were significantly higher in patients with CHD than in those without CHD (p <0.001). The significance persisted after adjusting for most major confounders. Patients with unstable angina pectoris had higher serum cathepsin L levels than those with stable angina pectoris (p = 0.02). Of patients with acute coronary syndrome, those with acute MI had higher serum cathepsin L levels than those with unstable angina pectoris (p <0.05) and patients with previous MI had the highest levels. Importantly, serum cathepsin L associated positively with number of coronary branch luminal narrowings (R = 0.38, p <0.001), Gensini scores (R = 0.44, p <0.001), high-sensitivity C-reactive protein (R = 0.32, p <0.001), fasting glucose (R = 0.16, p <0.03), and cigarette smokers (R = 0.27, p <0.001), but inversely with high-density lipoprotein (R = −0.23, p = 0.002) and apolipoprotein A1 (R = −0.19, p = 0.01) in all subjects. In conclusion, after adjusting for these confounders, we found that serum cathepsin L correlated positively and independently with Gensini score, suggesting that serum cathepsin L serves as a novel and independent biomarker for CHD.
AbstractList Higher levels of cysteinyl cathepsin L were detected in human atherosclerotic lesions than in healthy aortas. However, a link between human coronary heart disease (CHD) and systemic cathepsin L levels remains unknown. A total of 137 volunteers with diagnosed acute and previous myocardial infarction (MI) and stable and unstable angina pectoris in addition to 48 controls were asked to undergo coronary angiography. Serum cathepsin L, high-sensitivity C-reactive protein, fasting glucose, and lipid protein profiles were measured. Serum cathepsin L levels were significantly higher in patients with CHD than in those without CHD (p <0.001). The significance persisted after adjusting for most major confounders. Patients with unstable angina pectoris had higher serum cathepsin L levels than those with stable angina pectoris (p = 0.02). Of patients with acute coronary syndrome, those with acute MI had higher serum cathepsin L levels than those with unstable angina pectoris (p <0.05) and patients with previous MI had the highest levels. Importantly, serum cathepsin L associated positively with number of coronary branch luminal narrowings (R = 0.38, p <0.001), Gensini scores (R = 0.44, p <0.001), high-sensitivity C-reactive protein (R = 0.32, p <0.001), fasting glucose (R = 0.16, p <0.03), and cigarette smokers (R = 0.27, p <0.001), but inversely with high-density lipoprotein (R = −0.23, p = 0.002) and apolipoprotein A1 (R = −0.19, p = 0.01) in all subjects. In conclusion, after adjusting for these confounders, we found that serum cathepsin L correlated positively and independently with Gensini score, suggesting that serum cathepsin L serves as a novel and independent biomarker for CHD.
Higher levels of cysteinyl cathepsin L were detected in human atherosclerotic lesions than in healthy aortas. However, a link between human coronary heart disease (CHD) and systemic cathepsin L levels remains unknown. A total of 137 volunteers with diagnosed acute and previous myocardial infarction (MI) and stable and unstable angina pectoris in addition to 48 controls were asked to undergo coronary angiography. Serum cathepsin L, high-sensitivity C-reactive protein, fasting glucose, and lipid protein profiles were measured. Serum cathepsin L levels were significantly higher in patients with CHD than in those without CHD (p <0.001). The significance persisted after adjusting for most major confounders. Patients with unstable angina pectoris had higher serum cathepsin L levels than those with stable angina pectoris (p = 0.02). Of patients with acute coronary syndrome, those with acute MI had higher serum cathepsin L levels than those with unstable angina pectoris (p <0.05) and patients with previous MI had the highest levels. Importantly, serum cathepsin L associated positively with number of coronary branch luminal narrowings (R = 0.38, p <0.001), Gensini scores (R = 0.44, p <0.001), high-sensitivity C-reactive protein (R = 0.32, p <0.001), fasting glucose (R = 0.16, p <0.03), and cigarette smokers (R = 0.27, p <0.001), but inversely with high-density lipoprotein (R = -0.23, p = 0.002) and apolipoprotein A1 (R = -0.19, p = 0.01) in all subjects. In conclusion, after adjusting for these confounders, we found that serum cathepsin L correlated positively and independently with Gensini score, suggesting that serum cathepsin L serves as a novel and independent biomarker for CHD.
Higher levels of cysteinyl cathepsin L were detected in human atherosclerotic lesions than in healthy aortas. However, a link between human coronary heart disease (CHD) and systemic cathepsin L levels remains unknown. A total of 137 volunteers with diagnosed acute and previous myocardial infarction (MI) and stable and unstable angina pectoris in addition to 48 controls were asked to undergo coronary angiography. Serum cathepsin L, high-sensitivity C-reactive protein, fasting glucose, and lipid protein profiles were measured. Serum cathepsin L levels were significantly higher in patients with CHD than in those without CHD (p <0.001). The significance persisted after adjusting for most major confounders. Patients with unstable angina pectoris had higher serum cathepsin L levels than those with stable angina pectoris (p = 0.02). Of patients with acute coronary syndrome, those with acute MI had higher serum cathepsin L levels than those with unstable angina pectoris (p <0.05) and patients with previous MI had the highest levels. Importantly, serum cathepsin L associated positively with number of coronary branch luminal narrowings (R = 0.38, p <0.001), Gensini scores (R = 0.44, p <0.001), high-sensitivity C-reactive protein (R = 0.32, p <0.001), fasting glucose (R = 0.16, p <0.03), and cigarette smokers (R = 0.27, p <0.001), but inversely with high-density lipoprotein (R = -0.23, p = 0.002) and apolipoprotein A1 (R = -0.19, p = 0.01) in all subjects. In conclusion, after adjusting for these confounders, we found that serum cathepsin L correlated positively and independently with Gensini score, suggesting that serum cathepsin L serves as a novel and independent biomarker for CHD.Higher levels of cysteinyl cathepsin L were detected in human atherosclerotic lesions than in healthy aortas. However, a link between human coronary heart disease (CHD) and systemic cathepsin L levels remains unknown. A total of 137 volunteers with diagnosed acute and previous myocardial infarction (MI) and stable and unstable angina pectoris in addition to 48 controls were asked to undergo coronary angiography. Serum cathepsin L, high-sensitivity C-reactive protein, fasting glucose, and lipid protein profiles were measured. Serum cathepsin L levels were significantly higher in patients with CHD than in those without CHD (p <0.001). The significance persisted after adjusting for most major confounders. Patients with unstable angina pectoris had higher serum cathepsin L levels than those with stable angina pectoris (p = 0.02). Of patients with acute coronary syndrome, those with acute MI had higher serum cathepsin L levels than those with unstable angina pectoris (p <0.05) and patients with previous MI had the highest levels. Importantly, serum cathepsin L associated positively with number of coronary branch luminal narrowings (R = 0.38, p <0.001), Gensini scores (R = 0.44, p <0.001), high-sensitivity C-reactive protein (R = 0.32, p <0.001), fasting glucose (R = 0.16, p <0.03), and cigarette smokers (R = 0.27, p <0.001), but inversely with high-density lipoprotein (R = -0.23, p = 0.002) and apolipoprotein A1 (R = -0.19, p = 0.01) in all subjects. In conclusion, after adjusting for these confounders, we found that serum cathepsin L correlated positively and independently with Gensini score, suggesting that serum cathepsin L serves as a novel and independent biomarker for CHD.
Higher levels of cysteinyl cathepsin L were detected in human atherosclerotic lesions than in healthy aortas. However, a link between human coronary heart disease (CHD) and systemic cathepsin L levels remains unknown. A total of 137 volunteers with diagnosed acute and previous myocardial infarction (MI) and stable and unstable angina pectoris in addition to 48 controls were asked to undergo coronary angiography. Serum cathepsin L, high-sensitivity C-reactive protein, fasting glucose, and lipid protein profiles were measured. Serum cathepsin L levels were significantly higher in patients with CHD than in those without CHD (p <0.001). The significance persisted after adjusting for most major confounders. Patients with unstable angina pectoris had higher serum cathepsin L levels than those with stable angina pectoris (p = 0.02). Of patients with acute coronary syndrome, those with acute MI had higher serum cathepsin L levels than those with unstable angina pectoris (p <0.05) and patients with previous MI had the highest leve Importantly, serum cathepsin L associated positively with number of coronary branch luminal narrowings (R = 0.38, p <0.001), Gensini scores (R = 0.44, p <0.001), high-sensitivity C-reactive protein (R = 0.32, p <0.001), fasting glucose (R = 0.16, p <0.03), and cigarette smokers (R = 0.27, p <0.001), but inversely with high-density lipoprotein (R = -0.23, p = 0.002) and apolipoprotein A1 (R = -0.19, p = 0.01) in all subjects. In conclusion, after adjusting for these confounders, we found that serum cathepsin L correlated positively and independently with Gensini score, suggesting that serum cathepsin L serves as a novel and independent biomarker for CHD. [PUBLICATION ABSTRACT]
Author Peng, Daoquan
Xue, Yanqiong
Tan, Zheng
Shi, Guo-Ping
Liu, Yingxian
Li, Xiangping
Liu, Hongmin
Qing, Yingnan
AuthorAffiliation a Department of Medicine, Peking Union Medical College Hospital, Beijing, Central South University, Hunan, China
b Department of Cardiology, Second Xiangya Hospital, Central South University, Hunan, China
c Cardiovascular Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
AuthorAffiliation_xml – name: b Department of Cardiology, Second Xiangya Hospital, Central South University, Hunan, China
– name: c Cardiovascular Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
– name: a Department of Medicine, Peking Union Medical College Hospital, Beijing, Central South University, Hunan, China
Author_xml – sequence: 1
  givenname: Yingxian
  surname: Liu
  fullname: Liu, Yingxian
  organization: Department of Medicine, Peking Union Medical College Hospital, Beijing, China
– sequence: 2
  givenname: Xiangping
  surname: Li
  fullname: Li, Xiangping
  organization: Department of Cardiology, Second Xiangya Hospital, Central South University, Hunan, China
– sequence: 3
  givenname: Daoquan
  surname: Peng
  fullname: Peng, Daoquan
  organization: Department of Cardiology, Second Xiangya Hospital, Central South University, Hunan, China
– sequence: 4
  givenname: Zheng
  surname: Tan
  fullname: Tan, Zheng
  organization: Department of Cardiology, Second Xiangya Hospital, Central South University, Hunan, China
– sequence: 5
  givenname: Hongmin
  surname: Liu
  fullname: Liu, Hongmin
  organization: Department of Cardiology, Second Xiangya Hospital, Central South University, Hunan, China
– sequence: 6
  givenname: Yingnan
  surname: Qing
  fullname: Qing, Yingnan
  organization: Department of Cardiology, Second Xiangya Hospital, Central South University, Hunan, China
– sequence: 7
  givenname: Yanqiong
  surname: Xue
  fullname: Xue, Yanqiong
  organization: Department of Cardiology, Second Xiangya Hospital, Central South University, Hunan, China
– sequence: 8
  givenname: Guo-Ping
  surname: Shi
  fullname: Shi, Guo-Ping
  email: gshi@rics.bwh.harvard.edu
  organization: Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21139717$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19195505$$D View this record in MEDLINE/PubMed
BookMark eNqNUl2LEzEUDbLidld_ghIEfZuam_nIBHFF68cuFBTWxceQZu7YdKdJTWYW-u_N0Fq0IOtLQm7OOZx77zkjJ847JOQpsCkwqF6tpnq9Mjo0U85YnWpTBvCATKAWMgMJ-QmZMMZ4JqGQp-QsxlV6ApTVI3Ka_mVZsnJCzE3Edugcxkh9S68xDGs60_0SN9E6Oqc6Uu3olWtwg-lwPX1v_VqHWww0Ab7q3qZipN9tv6QzH7zTYUsvUYeefrARdcTH5GGru4hP9vc5ufn08dvsMpt_-Xw1ezfPTJVDnxWykHVhCi2rSoNYgGhZUehFW7RNXUNdNu2CgxamKaBiLM9BIC-NLFGWDS_z_Jxc7HQ3w2KNjUm-gu7UJtjkd6u8turvH2eX6oe_U1yUvKpGgZd7geB_Dhh7tbbRYNdph36IqqpqyYFVCfj8CLjyQ3CpOcVzlgsBuUigZ3_aOfj4PfwEeLEH6Gh01wbtjI0HHAfIpYBR6PUOZ4KPMWCrjO3T3P3Yhe0UMDVGQq3UPhJqjMRYTvtO7PKIfTByD-_tjodpZXcWg4omrdpgYwOaXjXe3qtwcaRgOutsavUWtxgPIwMVuWLqeozrmFZWM6hrwZLAm38L_IeBX5vr-88
CODEN AJCDAG
CitedBy_id crossref_primary_10_3892_ol_2019_11067
crossref_primary_10_2991_artres_k_191125_001
crossref_primary_10_1002_jcla_23608
crossref_primary_10_5005_jp_journals_10024_1019
crossref_primary_10_1016_j_cellsig_2020_109770
crossref_primary_10_1590_S0100_879X2010005000008
crossref_primary_10_1186_s13104_017_2940_y
crossref_primary_10_1155_2018_3091424
crossref_primary_10_1038_s41569_018_0002_3
crossref_primary_10_1016_j_jss_2019_06_102
crossref_primary_10_1002_prca_201300085
crossref_primary_10_1161_HYPERTENSIONAHA_124_22903
crossref_primary_10_3736_jcim20100908
crossref_primary_10_1039_c2ib20197f
crossref_primary_10_1161_CIRCULATIONAHA_111_066712
crossref_primary_10_4068_cmj_2012_48_2_77
crossref_primary_10_1093_cvr_cvab204
crossref_primary_10_1016_j_bmcl_2012_09_086
crossref_primary_10_1038_srep13855
crossref_primary_10_1371_journal_pone_0187494
crossref_primary_10_3892_etm_2019_8222
crossref_primary_10_1016_j_atherosclerosis_2011_02_016
crossref_primary_10_1161_HYPERTENSIONAHA_111_180935
crossref_primary_10_1016_j_atherosclerosis_2015_06_017
crossref_primary_10_1186_1479_5876_9_109
crossref_primary_10_1016_j_biochi_2015_10_010
crossref_primary_10_1039_c3ob41341a
crossref_primary_10_1039_D1OB00225B
crossref_primary_10_1016_j_bbapap_2020_140360
crossref_primary_10_1016_j_atherosclerosis_2016_09_062
crossref_primary_10_1007_s11010_016_2924_6
crossref_primary_10_1093_cvr_cvq328
crossref_primary_10_1002_oby_22660
crossref_primary_10_1016_j_biochi_2010_03_011
crossref_primary_10_1016_j_ijbiomac_2020_11_185
crossref_primary_10_1097_FJC_0000000000000522
crossref_primary_10_1007_s10142_024_01391_2
crossref_primary_10_1016_j_bbadis_2014_04_032
crossref_primary_10_1016_j_yjmcc_2018_11_010
crossref_primary_10_1002_cmdc_202000823
crossref_primary_10_1177_147323001003800421
crossref_primary_10_3349_ymj_2014_55_4_912
crossref_primary_10_1016_j_peptides_2013_01_011
Cites_doi 10.1161/01.CIR.92.8.2127
10.1016/S0735-1097(00)00804-4
10.1161/01.ATV.0000227470.72109.2b
10.1016/S0033-8389(22)02831-7
10.1016/j.atherosclerosis.2005.05.012
10.1016/j.vetpar.2005.10.016
10.1126/science.280.5362.450
10.1016/j.atherosclerosis.2005.08.001
10.1016/S0002-9149(83)80105-2
10.1172/JCI181
10.1161/01.ATV.0000134530.27208.41
10.1093/ndt/gfh374
10.1111/j.1600-065X.1999.tb01360.x
10.1096/fj.05-5517fje
10.2353/ajpath.2008.071126
10.1016/j.atherosclerosis.2006.11.013
10.1161/CIRCULATIONAHA.107.688523
10.1536/jhj.43.607
10.1146/annurev.physiol.59.1.63
10.1016/S1535-6108(04)00111-4
10.1161/01.CIR.80.2.410
10.1038/nm1182
10.1136/jcp.2006.038729
10.1359/jbmr.060614
10.1196/annals.1329.053
10.1111/j.1582-4934.2004.tb00469.x
10.1073/pnas.092637699
ContentType Journal Article
Copyright 2009 Elsevier Inc.
Elsevier Inc.
2009 INIST-CNRS
Copyright Elsevier Sequoia S.A. Feb 15, 2009
2009 Elsevier Inc. 2009
Copyright_xml – notice: 2009 Elsevier Inc.
– notice: Elsevier Inc.
– notice: 2009 INIST-CNRS
– notice: Copyright Elsevier Sequoia S.A. Feb 15, 2009
– notice: 2009 Elsevier Inc. 2009
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7TS
8FD
FR3
K9.
M7Z
NAPCQ
P64
7X8
5PM
DOI 10.1016/j.amjcard.2008.10.011
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Physical Education Index
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biochemistry Abstracts 1
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Nursing & Allied Health Premium
Technology Research Database
Biochemistry Abstracts 1
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Physical Education Index
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic

Nursing & Allied Health Premium


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-1913
EndPage 481
ExternalDocumentID PMC2752663
1643440011
19195505
21139717
10_1016_j_amjcard_2008_10_011
S0002914908018870
1_s2_0_S0002914908018870
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: R01 HL067283
– fundername: NHLBI NIH HHS
  grantid: R01 HL081090
– fundername: NHLBI NIH HHS
  grantid: HL81090
– fundername: NHLBI NIH HHS
  grantid: HL60942
– fundername: NHLBI NIH HHS
  grantid: HL67283
– fundername: NHLBI NIH HHS
  grantid: R01 HL060942
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
123
1B1
1CY
1P~
1RT
1~.
1~5
23M
3O-
4.4
457
4G.
53G
5RE
5VS
6J9
7-5
71M
7RV
7X7
88E
8FI
8FJ
8G5
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAQFI
AAQQT
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABPPZ
ABUWG
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACIWK
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADMUD
ADNMO
ADUKH
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFKRA
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
AZQEC
BENPR
BKEYQ
BKOJK
BKOMP
BLXMC
BNPGV
BPHCQ
BVXVI
CCPQU
CS3
DWQXO
EBS
EFJIC
EFKBS
EJD
EMOBN
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
FYUFA
G-2
G-Q
GBLVA
GNUQQ
GUQSH
HEB
HMCUK
HMK
HMO
HVGLF
HZ~
IH2
IHE
J1W
J5H
K-O
KOM
L7B
M1P
M29
M2O
M41
MO0
N9A
NAPCQ
O-L
O9-
OA.
OAUVE
OHT
OL~
OVD
OZT
P-8
P-9
P2P
PC.
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
Q38
R2-
ROL
RPZ
SAE
SDF
SDG
SEL
SES
SJN
SPCBC
SSH
SSZ
SV3
T5K
TEORI
TWZ
UKHRP
UNMZH
UV1
WH7
WOW
WUQ
X7M
XPP
YFH
YOC
YQJ
YYP
YZZ
Z5R
ZGI
ZXP
~G-
3V.
AACTN
AAYOK
AFCTW
AFKWA
AJOXV
ALIPV
AMFUW
PKN
RIG
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
EFLBG
LCYCR
ZA5
AAYXX
AGRNS
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7TS
8FD
FR3
K9.
M7Z
P64
7X8
5PM
ID FETCH-LOGICAL-c631t-494984c4a966a17b17f044abf4fd88185dfb21a7cd416003317e25c95e95d2533
IEDL.DBID AIKHN
ISSN 0002-9149
1879-1913
IngestDate Thu Aug 21 14:36:01 EDT 2025
Thu Aug 07 15:31:02 EDT 2025
Sat Jul 26 02:24:21 EDT 2025
Mon Jul 21 06:06:10 EDT 2025
Mon Jul 21 09:14:52 EDT 2025
Tue Jul 01 01:52:41 EDT 2025
Thu Apr 24 23:03:49 EDT 2025
Fri Feb 23 02:27:28 EST 2024
Sun Feb 23 10:19:00 EST 2025
Tue Aug 26 18:33:33 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Human
Peptidases
Cathepsin L
Enzyme
Cysteine endopeptidases
Biological marker
Hydrolases
Cardiovascular disease
Serum
Circulatory system
Cardiology
Coronary heart disease
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c631t-494984c4a966a17b17f044abf4fd88185dfb21a7cd416003317e25c95e95d2533
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
Corresponding author: Tel: 617-525-4358; or 86-139-7-487-9019 (X. Li); fax: 617-525-4380. E-mail address: gshi@rics.bwh.harvard.edu (G.-P. Shi).
OpenAccessLink http://doi.org/10.1016/j.amjcard.2008.10.011
PMID 19195505
PQID 230377137
PQPubID 41200
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2752663
proquest_miscellaneous_66892106
proquest_journals_230377137
pubmed_primary_19195505
pascalfrancis_primary_21139717
crossref_citationtrail_10_1016_j_amjcard_2008_10_011
crossref_primary_10_1016_j_amjcard_2008_10_011
elsevier_sciencedirect_doi_10_1016_j_amjcard_2008_10_011
elsevier_clinicalkeyesjournals_1_s2_0_S0002914908018870
elsevier_clinicalkey_doi_10_1016_j_amjcard_2008_10_011
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-02-15
PublicationDateYYYYMMDD 2009-02-15
PublicationDate_xml – month: 02
  year: 2009
  text: 2009-02-15
  day: 15
PublicationDecade 2000
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
– name: New York
PublicationTitle The American journal of cardiology
PublicationTitleAlternate Am J Cardiol
PublicationYear 2009
Publisher Elsevier Inc
Elsevier
Elsevier Limited
Publisher_xml – name: Elsevier Inc
– name: Elsevier
– name: Elsevier Limited
References Liu, Sukhova, Sun, Xu, Libby, Shi (bib19) 2004; 24
Joyce, Baruch, Chehade, Meyer-Morse, Giraudo, Tsai, Greenbaum, Hager, Bogyo, Hanahan (bib9) 2004; 5
Sriveny, Raina, Yadav, Chandra, Jayraw, Singh, Velusamy, Singh (bib12) 2006; 135
Geluk, Post, Hillege, Tio, Tijssen, van Dijk, Dijk, Bakker, de Jong, van Gilst, Zijlstra (bib24) 2008; 196
Vonend, Apel, Amann, Sellin, Stegbauer, Ritz, Rump (bib10) 2004; 19
Sukhova, Shi, Simon, Chapman, Libby (bib6) 1998; 102
Braunward (bib15) 1989; 80
Urbich, Heeschen, Aicher, Sasaki, Bruhl, Farhadi, Vajkoczy, Hofmann, Peters, Pennacchio (bib3) 2005; 11
Kitamoto, Sukhova, Sun, Yang, Libby, Love, Duramad, Sun, Zhang, Yang, Peters, Shi (bib5) 2007; 115
Everts, Korper, Hoeben, Jansen, Bromme, Cleutjens, Heeneman, Peters, Reinheckel, Saftig, Beertsen (bib13) 2006; 21
Liu, Sukhova, Yang, Sun, Ma, Ren, Xu, Fu, Dolganov, Hu, Libby, Shi (bib1) 2006; 184
Gensini (bib17) 1983; 51
Adams, Nakagomi, Keech, Robinson, McCredie, Bailey, Freedman, Celermajer (bib20) 1995; 92
Auer, Berent, Lassnig, Eber (bib18) 2002; 43
Villadangos, Bryant, Deussing, Driessen, Lennon-Duménil, Riese, Roth, Saftig, Shi, Chapman, Peters, Ploegh (bib8) 1999; 172
Li, Yuan (bib2) 2004; 1030
Stypmann, Gläser, Roth, Tobin, Petermann, Matthias, Mönnig, Haverkamp, Breithardt, Schmahl, Peters, Reinheckel (bib27) 2002; 99
Cheng, Murohara, Kuzuya, Izawa, Sasaki, Obata, Nagata, Nishizawa, Kobayashi, Yamada (bib22) 2008; 173
Norja, Nuutila, Karhunen, Goebeler (bib23) 2007; 60
Ding, Yin (bib11) 2004; 8
Petermann, Mayer, Stypmann, Biniossek, Tobin, Engelen, Dandekar, Grune, Schild, Peters, Reinheckel (bib26) 2006; 20
Chapman, Riese, Shi (bib7) 1997; 59
Liu, Ma, Yang, Ren, Sun, Yan, Sun, Fu, Xu, Hu, Shi (bib25) 2006; 186
Alpert, Thygesen, Antman, Bassand (bib14) 2000; 36
Platt, Ankeny, Jo (bib21) 2006; 26
Nakagawa, Roth, Wong, Nelson, Farr, Deussing, Villadangos, Ploegh, Peters, Rudensky (bib4) 1998; 280
Judkins (bib16) 1968; 6
Joyce (10.1016/j.amjcard.2008.10.011_bib9) 2004; 5
Gensini (10.1016/j.amjcard.2008.10.011_bib17) 1983; 51
Everts (10.1016/j.amjcard.2008.10.011_bib13) 2006; 21
Sriveny (10.1016/j.amjcard.2008.10.011_bib12) 2006; 135
Petermann (10.1016/j.amjcard.2008.10.011_bib26) 2006; 20
Villadangos (10.1016/j.amjcard.2008.10.011_bib8) 1999; 172
Platt (10.1016/j.amjcard.2008.10.011_bib21) 2006; 26
Auer (10.1016/j.amjcard.2008.10.011_bib18) 2002; 43
Liu (10.1016/j.amjcard.2008.10.011_bib19) 2004; 24
Liu (10.1016/j.amjcard.2008.10.011_bib1) 2006; 184
Li (10.1016/j.amjcard.2008.10.011_bib2) 2004; 1030
Vonend (10.1016/j.amjcard.2008.10.011_bib10) 2004; 19
Braunward (10.1016/j.amjcard.2008.10.011_bib15) 1989; 80
Geluk (10.1016/j.amjcard.2008.10.011_bib24) 2008; 196
Liu (10.1016/j.amjcard.2008.10.011_bib25) 2006; 186
Nakagawa (10.1016/j.amjcard.2008.10.011_bib4) 1998; 280
Sukhova (10.1016/j.amjcard.2008.10.011_bib6) 1998; 102
Adams (10.1016/j.amjcard.2008.10.011_bib20) 1995; 92
Kitamoto (10.1016/j.amjcard.2008.10.011_bib5) 2007; 115
Ding (10.1016/j.amjcard.2008.10.011_bib11) 2004; 8
Cheng (10.1016/j.amjcard.2008.10.011_bib22) 2008; 173
Stypmann (10.1016/j.amjcard.2008.10.011_bib27) 2002; 99
Alpert (10.1016/j.amjcard.2008.10.011_bib14) 2000; 36
Chapman (10.1016/j.amjcard.2008.10.011_bib7) 1997; 59
Urbich (10.1016/j.amjcard.2008.10.011_bib3) 2005; 11
Judkins (10.1016/j.amjcard.2008.10.011_bib16) 1968; 6
Norja (10.1016/j.amjcard.2008.10.011_bib23) 2007; 60
References_xml – volume: 92
  start-page: 2127
  year: 1995
  end-page: 2134
  ident: bib20
  article-title: Carotid intima–media thickness is only weakly correlated with the extent and severity of coronary artery disease
  publication-title: Circulation
– volume: 43
  start-page: 607
  year: 2002
  end-page: 619
  ident: bib18
  article-title: C-reactive protein and coronary artery disease
  publication-title: Jpn Heart J
– volume: 24
  start-page: 1359
  year: 2004
  end-page: 1366
  ident: bib19
  article-title: Lysosomal cysteine proteases in atherosclerosis
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 186
  start-page: 411
  year: 2006
  end-page: 419
  ident: bib25
  article-title: Increased serum cathepsin S in patients with atherosclerosis and diabetes
  publication-title: Atherosclerosis
– volume: 102
  start-page: 576
  year: 1998
  end-page: 583
  ident: bib6
  article-title: Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells
  publication-title: J Clin Invest
– volume: 60
  start-page: 545
  year: 2007
  end-page: 548
  ident: bib23
  article-title: C-reactive protein in vulnerable coronary plaques
  publication-title: J Clin Pathol
– volume: 20
  start-page: 1266
  year: 2006
  end-page: 1268
  ident: bib26
  article-title: Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice
  publication-title: FASEB J
– volume: 99
  start-page: 6234
  year: 2002
  end-page: 6239
  ident: bib27
  article-title: Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L
  publication-title: Proc Natl Acad Sci U S A
– volume: 11
  start-page: 206
  year: 2005
  end-page: 213
  ident: bib3
  article-title: Cathepsin L is required for endothelial progenitor cell-induced neovascularization
  publication-title: Nat Med
– volume: 280
  start-page: 394
  year: 1998
  end-page: 395
  ident: bib4
  article-title: Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus
  publication-title: Science
– volume: 21
  start-page: 1399
  year: 2006
  end-page: 1408
  ident: bib13
  article-title: Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone
  publication-title: Bone Miner Res
– volume: 26
  start-page: 1784
  year: 2006
  end-page: 1790
  ident: bib21
  article-title: Laminar shear stress inhibits cathepsin L activity in endothelial cells
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 51
  start-page: 606
  year: 1983
  ident: bib17
  article-title: A more meaningful scoring system for determining the severity of coronary heart disease
  publication-title: Am J Cardiol
– volume: 196
  start-page: 372
  year: 2008
  end-page: 382
  ident: bib24
  article-title: C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: data from the prospective PREVEND cohort
  publication-title: Atherosclerosis
– volume: 135
  start-page: 25
  year: 2006
  end-page: 31
  ident: bib12
  article-title: Cathepsin L cysteine proteinase in the diagnosis of bovine Fasciola gigantica infection
  publication-title: Vet Parasitol
– volume: 59
  start-page: 63
  year: 1997
  end-page: 88
  ident: bib7
  article-title: Emerging roles for cysteine proteases in human biology
  publication-title: Annu Rev Physiol
– volume: 173
  start-page: 358
  year: 2008
  end-page: 369
  ident: bib22
  article-title: Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment
  publication-title: Am J Pathol
– volume: 36
  start-page: 959
  year: 2000
  end-page: 969
  ident: bib14
  article-title: Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction
  publication-title: J Am Coll Cardiol
– volume: 8
  start-page: 445
  year: 2004
  end-page: 454
  ident: bib11
  article-title: Dissection of the multiple mechanisms of TNF-alpha–induced apoptosis in liver injury
  publication-title: J Cell Mol Med
– volume: 172
  start-page: 109
  year: 1999
  end-page: 120
  ident: bib8
  article-title: Proteases involved in MHC class II antigen presentation
  publication-title: Immunol Rev
– volume: 184
  start-page: 302
  year: 2006
  end-page: 311
  ident: bib1
  article-title: Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells
  publication-title: Atherosclerosis
– volume: 1030
  start-page: 427
  year: 2004
  end-page: 433
  ident: bib2
  article-title: Increased expression and translocation of lysosomal cathepsins contribute to macrophage apoptosis in atherogenesis
  publication-title: Ann N Y Acad Sci
– volume: 5
  start-page: 443
  year: 2004
  end-page: 453
  ident: bib9
  article-title: Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis
  publication-title: Cancer Cell
– volume: 6
  start-page: 467
  year: 1968
  end-page: 492
  ident: bib16
  article-title: Percutaneous transfemoral selective coronary arteriography
  publication-title: Radiol Clin North Am
– volume: 115
  start-page: 2065
  year: 2007
  end-page: 2075
  ident: bib5
  article-title: Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice
  publication-title: Circulation
– volume: 80
  start-page: 410
  year: 1989
  end-page: 414
  ident: bib15
  article-title: Unstable angina: a classification
  publication-title: Circulation
– volume: 19
  start-page: 2217
  year: 2004
  end-page: 2222
  ident: bib10
  article-title: Modulation of gene expression by moxonidine in rats with chronic renal failure
  publication-title: Nephrol Dial Transplant
– volume: 92
  start-page: 2127
  year: 1995
  ident: 10.1016/j.amjcard.2008.10.011_bib20
  article-title: Carotid intima–media thickness is only weakly correlated with the extent and severity of coronary artery disease
  publication-title: Circulation
  doi: 10.1161/01.CIR.92.8.2127
– volume: 36
  start-page: 959
  year: 2000
  ident: 10.1016/j.amjcard.2008.10.011_bib14
  article-title: Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction
  publication-title: J Am Coll Cardiol
  doi: 10.1016/S0735-1097(00)00804-4
– volume: 26
  start-page: 1784
  year: 2006
  ident: 10.1016/j.amjcard.2008.10.011_bib21
  article-title: Laminar shear stress inhibits cathepsin L activity in endothelial cells
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.0000227470.72109.2b
– volume: 6
  start-page: 467
  year: 1968
  ident: 10.1016/j.amjcard.2008.10.011_bib16
  article-title: Percutaneous transfemoral selective coronary arteriography
  publication-title: Radiol Clin North Am
  doi: 10.1016/S0033-8389(22)02831-7
– volume: 184
  start-page: 302
  year: 2006
  ident: 10.1016/j.amjcard.2008.10.011_bib1
  article-title: Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2005.05.012
– volume: 135
  start-page: 25
  year: 2006
  ident: 10.1016/j.amjcard.2008.10.011_bib12
  article-title: Cathepsin L cysteine proteinase in the diagnosis of bovine Fasciola gigantica infection
  publication-title: Vet Parasitol
  doi: 10.1016/j.vetpar.2005.10.016
– volume: 280
  start-page: 394
  year: 1998
  ident: 10.1016/j.amjcard.2008.10.011_bib4
  article-title: Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus
  publication-title: Science
  doi: 10.1126/science.280.5362.450
– volume: 186
  start-page: 411
  year: 2006
  ident: 10.1016/j.amjcard.2008.10.011_bib25
  article-title: Increased serum cathepsin S in patients with atherosclerosis and diabetes
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2005.08.001
– volume: 51
  start-page: 606
  year: 1983
  ident: 10.1016/j.amjcard.2008.10.011_bib17
  article-title: A more meaningful scoring system for determining the severity of coronary heart disease
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(83)80105-2
– volume: 102
  start-page: 576
  year: 1998
  ident: 10.1016/j.amjcard.2008.10.011_bib6
  article-title: Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells
  publication-title: J Clin Invest
  doi: 10.1172/JCI181
– volume: 24
  start-page: 1359
  year: 2004
  ident: 10.1016/j.amjcard.2008.10.011_bib19
  article-title: Lysosomal cysteine proteases in atherosclerosis
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.0000134530.27208.41
– volume: 19
  start-page: 2217
  year: 2004
  ident: 10.1016/j.amjcard.2008.10.011_bib10
  article-title: Modulation of gene expression by moxonidine in rats with chronic renal failure
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfh374
– volume: 172
  start-page: 109
  year: 1999
  ident: 10.1016/j.amjcard.2008.10.011_bib8
  article-title: Proteases involved in MHC class II antigen presentation
  publication-title: Immunol Rev
  doi: 10.1111/j.1600-065X.1999.tb01360.x
– volume: 20
  start-page: 1266
  year: 2006
  ident: 10.1016/j.amjcard.2008.10.011_bib26
  article-title: Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice
  publication-title: FASEB J
  doi: 10.1096/fj.05-5517fje
– volume: 173
  start-page: 358
  year: 2008
  ident: 10.1016/j.amjcard.2008.10.011_bib22
  article-title: Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2008.071126
– volume: 196
  start-page: 372
  year: 2008
  ident: 10.1016/j.amjcard.2008.10.011_bib24
  article-title: C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: data from the prospective PREVEND cohort
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2006.11.013
– volume: 115
  start-page: 2065
  year: 2007
  ident: 10.1016/j.amjcard.2008.10.011_bib5
  article-title: Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.107.688523
– volume: 43
  start-page: 607
  year: 2002
  ident: 10.1016/j.amjcard.2008.10.011_bib18
  article-title: C-reactive protein and coronary artery disease
  publication-title: Jpn Heart J
  doi: 10.1536/jhj.43.607
– volume: 59
  start-page: 63
  year: 1997
  ident: 10.1016/j.amjcard.2008.10.011_bib7
  article-title: Emerging roles for cysteine proteases in human biology
  publication-title: Annu Rev Physiol
  doi: 10.1146/annurev.physiol.59.1.63
– volume: 5
  start-page: 443
  year: 2004
  ident: 10.1016/j.amjcard.2008.10.011_bib9
  article-title: Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis
  publication-title: Cancer Cell
  doi: 10.1016/S1535-6108(04)00111-4
– volume: 80
  start-page: 410
  year: 1989
  ident: 10.1016/j.amjcard.2008.10.011_bib15
  article-title: Unstable angina: a classification
  publication-title: Circulation
  doi: 10.1161/01.CIR.80.2.410
– volume: 11
  start-page: 206
  year: 2005
  ident: 10.1016/j.amjcard.2008.10.011_bib3
  article-title: Cathepsin L is required for endothelial progenitor cell-induced neovascularization
  publication-title: Nat Med
  doi: 10.1038/nm1182
– volume: 60
  start-page: 545
  year: 2007
  ident: 10.1016/j.amjcard.2008.10.011_bib23
  article-title: C-reactive protein in vulnerable coronary plaques
  publication-title: J Clin Pathol
  doi: 10.1136/jcp.2006.038729
– volume: 21
  start-page: 1399
  year: 2006
  ident: 10.1016/j.amjcard.2008.10.011_bib13
  article-title: Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone
  publication-title: Bone Miner Res
  doi: 10.1359/jbmr.060614
– volume: 1030
  start-page: 427
  year: 2004
  ident: 10.1016/j.amjcard.2008.10.011_bib2
  article-title: Increased expression and translocation of lysosomal cathepsins contribute to macrophage apoptosis in atherogenesis
  publication-title: Ann N Y Acad Sci
  doi: 10.1196/annals.1329.053
– volume: 8
  start-page: 445
  year: 2004
  ident: 10.1016/j.amjcard.2008.10.011_bib11
  article-title: Dissection of the multiple mechanisms of TNF-alpha–induced apoptosis in liver injury
  publication-title: J Cell Mol Med
  doi: 10.1111/j.1582-4934.2004.tb00469.x
– volume: 99
  start-page: 6234
  year: 2002
  ident: 10.1016/j.amjcard.2008.10.011_bib27
  article-title: Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.092637699
SSID ssj0001156
Score 2.139493
Snippet Higher levels of cysteinyl cathepsin L were detected in human atherosclerotic lesions than in healthy aortas. However, a link between human coronary heart...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 476
SubjectTerms Angina, Unstable - blood
Angina, Unstable - diagnostic imaging
Biological and medical sciences
Biomarkers
Biomarkers - blood
Blood Glucose - analysis
C-Reactive Protein - analysis
Cardiology
Cardiology. Vascular system
Cardiovascular
Cardiovascular disease
Case-Control Studies
Cathepsin L
Cathepsins - blood
Cigarettes
Coronary Angiography
Coronary Disease - blood
Coronary Disease - diagnostic imaging
Coronary heart disease
Coronary vessels
Cysteine Endopeptidases - blood
Female
Heart
Humans
Male
Medical imaging
Medical sciences
Middle Aged
Myocardial Infarction - blood
Myocardial Infarction - diagnostic imaging
Smoking
Title Usefulness of Serum Cathepsin L as an Independent Biomarker in Patients With Coronary Heart Disease
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0002914908018870
https://www.clinicalkey.es/playcontent/1-s2.0-S0002914908018870
https://dx.doi.org/10.1016/j.amjcard.2008.10.011
https://www.ncbi.nlm.nih.gov/pubmed/19195505
https://www.proquest.com/docview/230377137
https://www.proquest.com/docview/66892106
https://pubmed.ncbi.nlm.nih.gov/PMC2752663
Volume 103
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGJiEkNPE5ukHxA69pY8eJ48dRmDrYpglRsTfLcWwt1ZpWTfrAC38758TJKAwN8Rrn0vp8d_6d7guhdzriSovMBIxmScDiGHTORiwIaW7jnAFRM77t_CKZztinq_hqB026WhiXVultf2vTG2vtn4w9N8eronA1viEVxAWuQgKqAn77Ho1EAqK9d3z6eXrRG2QAPUmHgh3BbSHPeD5Si7mGs2izKl2eFyF_u6Ier1QFjLPtxIu7IOnvmZW_XFUnT9C-x5j4uN3GU7Rjymfo4bmPoj9HelYZu7lxRg4vLQZzsVngphRwVRUlPsOqwqrEp_2E3Bq_L5YLl8izxvDCZduLtcLfivoaT1wPBLX-jqegNDX-0EZ8XqDZycevk2nghy0EOolIHbguNSnTTIH_owjPCLchYyqzzOapu9Vzm1GiuM4BwrkJcIQbGmsRGxHnFEDjS7RbLkvzCuFmyJ8Js4jDR6mgKhNxaqzVzLo6WD5ArOOv1L4TuRuIcSO7lLO59MfSTsmEx3AsAzTqyVZtK477CJLu8GRXZwqWUcJlcR8hv4vQVF6_K0lkRWUo_5DBAUp7yi0x_pcfHW7JV79HcNEBNBJg21EncLL_I-BBRpyTCFbf9qtgIVzYR5VmualkkqQCHPtkgA5a4bzlniDCeaiw3y2x7V9wvce3V8riuulBTnkM0C46_P_9HqFHbWSOBiR-jXbr9ca8AYBXZ0P0YPSDDEGNJ1_OLodenX8C-LRRAA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1db9Mw0JqGBEgI8TnKYPMDr2ljx46TRyhMHbQTD6vYm-U4tpZqTasmfeCF3845TlIKQ0O8xr4kd7473-m-EHqnI6F0mpmA0SwOGOcgczZiQUhzy3MGQM34ttlFPJmzz1f86gCNu1oYl1bZ6n6v0xtt3T4ZtdQcrYvC1fiGNCUucBUSEBXw2-8xEF8nncMfuzwPMHnizgZ223dlPKPFUC0XGk7C51S6LC9C_nZBPVqrCshm_byL2wzS3_Mqf7mozp6gx62Fid97JJ6iA1M-Q_dnbQz9OdLzytjtjVNxeGUxKIvtEjeFgOuqKPEUqwqrEp_383Fr_KFYLV0azwbDhq--E2uFvxX1NR67Dghq8x1PQGRq_NHHe16g-dmny_EkaEctBDqOSB24HjUJ00yB96OIyIiwIWMqs8zmibvTc5tRooTOwYBz89-IMJTrlJuU5xRMxpfosFyV5hXCzYg_E2aRgJfSlKos5YmxVjPrqmDFALGOvlK3fcjdOIwb2SWcLWR7LH5GJjyGYxmgYQ-29o047gKIu8OTXZUp6EUJV8VdgOI2QFO10l1JIisqQ_kHBw5Q0kPuMfG_fPRkj796HMFBB5ORANmOO4aT_Y-A_xgJQSJYPe1XQT-4oI8qzWpbyThOUnDr4wE68sy5o15KUuefAr57bNtvcJ3H91fK4rrpQE4FB8Muev3_-J6iB5PL2VROzy--HKOHPkZHA8LfoMN6szVvwdSrs5NGlH8CPn1QLw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Usefulness+of+serum+cathepsin+L+as+an+independent+biomarker+in+patients+with+coronary+heart+disease&rft.jtitle=The+American+journal+of+cardiology&rft.au=Liu%2C+Yingxian&rft.au=Li%2C+Xiangping&rft.au=Peng%2C+Daoquan&rft.au=Tan%2C+Zheng&rft.date=2009-02-15&rft.eissn=1879-1913&rft.volume=103&rft.issue=4&rft.spage=476&rft_id=info:doi/10.1016%2Fj.amjcard.2008.10.011&rft_id=info%3Apmid%2F19195505&rft.externalDocID=19195505
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00029149%2FS0002914908X00384%2Fcov150h.gif